FeesSafety
Pluang+

Electra Therapeutics offers cash-backed potential after IPO drop, with key trial data and pipeline valued at $150M.

Market News
17 Nov 2026, 09:47 WIB
Seeking Alpha
View Source
Neutral
Electra Therapeutics offers cash-backed potential after IPO drop, with key trial data and pipeline valued at $150M.

Electra Therapeutics' stock fell after its IPO, but the company remains financially strong with cash to fund operations through 2029. Its drug ipsoprubart showed promising 100% eight-week survival in a small frontline patient group, supporting further trials. The company’s pipeline is valued around $150 million, with upcoming data expected in 2027 and plans to expand into oncology. Key risks include regulatory acceptance of trial comparators and potential financing needs or competition.

Electra Therapeutics' recent IPO and pipeline developments provide context for health sector trends. For readers following the health sector, here is Pluang's market snapshot as of Nov 17, 2026 14:41 WIB: out of 150 priced US health stocks, 37 rose and 109 fell. Notable movers include BNGO at USD 0.94 with a 5.62% drop, DFTX at USD 30.30 down 5.55%, and EXEL at USD 65.50 down 5.07%.

More News

Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics secured $60 million in seed funding led by Ackermans & van Haaren with participation from AbbVie Ventures, M Ventures, and others. The funds will support clinical development of COM002, a first-in-class immune engager targeting cance...

Company Fundamentals
Bullish
2 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes announced at its 2026 Capital Markets Day a new growth cycle aiming for double-digit revenue and EPS growth by 2029, targeting over €8 billion in revenue and €1.80 in non-IFRS diluted EPS. The company highlights its transition to su...

Market News
Bullish
2 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029, driven by AI and subscription model.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029, driven by AI and subscription model.

Dassault Systèmes announced a new growth cycle aiming for double-digit increases in revenue and diluted EPS by 2029, with revenue expected to exceed €8 billion and EPS €1.80. This growth is supported by a strong subscription model, accelerating adopt...

Company Fundamentals
Bullish
2 hours ago
Elbit Systems reports Q3 revenue up 17%, net income growth over 30%, and record $33B backlog.

Elbit Systems reports Q3 revenue up 17%, net income growth over 30%, and record $33B backlog.

Elbit Systems posted strong Q3 2026 results with revenues rising 17% to $2.3 billion and GAAP net income increasing over 30% to $177.9 million. The company’s order backlog reached a record $33 billion, driven mainly by European orders. Growth was sup...

Company Fundamentals
Bullish
5 hours ago
Wells Fargo doubles BlackRock Bitcoin ETF holdings to $2.35B, gaining exposure to 28,070 BTC by September.

Wells Fargo doubles BlackRock Bitcoin ETF holdings to $2.35B, gaining exposure to 28,070 BTC by September.

Wells Fargo reported holding 49.58 million shares of BlackRock’s iShares Bitcoin Trust (IBIT) worth about $2.35 billion at the end of September, more than doubling its position from June. This increase reflects a 103% rise in share count and a 42% ri...

Market News
Bullish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App